Plasma acylated and plasma unacylated ghrelin: useful new biomarkers in patients with neuroendocrine tumors?

To date, the value of fasting plasma acylated ghrelin (AG) and unacylated ghrelin (UAG) as potential novel biomarkers in patients with neuroendocrine tumors (NETs) is unknown. The aims of this study are to (i) compare fasting AG and UAG levels between nonobese, nondiabetic NET patients (N=28) and ag...

Descripción completa

Detalles Bibliográficos
Autores principales: van Adrichem, Roxanne C S, van der Lely, Aart Jan, Huisman, Martin, Kramer, Piet, Feelders, Richard A, Delhanty, Patric J D, de Herder, Wouter W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002960/
https://www.ncbi.nlm.nih.gov/pubmed/27215920
http://dx.doi.org/10.1530/EC-16-0021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002960/
https://www.ncbi.nlm.nih.gov/pubmed/27215920
http://dx.doi.org/10.1530/EC-16-0021

Ejemplares similares